Aptevo Therapeutics Inc. shares surged nearly 50% early Thursday on promising leukemia trial results, before paring gains in ...

NORTHAMPTON, MA / ACCESSWIRE / December 12, 2024 / IlluminaThe comprehensive method provides improved detection and greater ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

Two of three patients achieved both complete remission and MRD-negative status High response rates observed in earlier studies continue in ongoing mipletamig trial Cohort 2 enrollment commencing ...

A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies ...

In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Argenx Se (ARGX – Research Report), with a price target of ...

The global Hematopoietic Stem Cell Transplantation Market is worth USD 7 Billion as of now and expected to reach USD 15 ...

Cincinnati Bengals wide receiver Ja'Marr Chase danced a touchdown celebration against the Dallas Cowboys in honor of Texas boy's Brixton Wood cancer battle.

Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...

By Nancy Lapid (Reuters) - Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, ...